New guideline details how to manage CVD risk before, during & after noncardiac surgery

Expanded definition of cardiovascular risk related to noncardiac surgery timing and risk, new ways to avoid unnecessary and costly screening, and recommendations for managing patients taking SGLT2-inhibitors are among the updates in the new 2024 joint guideline from the American Heart Association and the American College of Cardiology, endorsed by seven other medical societies